Passage Bio (PASG) Insider Trading & Ownership $6.95 -0.05 (-0.71%) Closing price 09/15/2025 03:53 PM EasternExtended Trading$7.09 +0.14 (+2.07%) As of 04:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Passage Bio (NASDAQ:PASG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.37MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$762.24K Get PASG Insider Trade Alerts Want to know when executives and insiders are buying or selling Passage Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PASG Insider Buying and Selling by Quarter Passage Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2025Lynx1 Capital Management LpMajor ShareholderBuy11,900$6.99$83,181.00 9/12/2025Lynx1 Capital Management LpMajor ShareholderBuy19,783$6.99$138,283.17 9/11/2025Lynx1 Capital Management LpMajor ShareholderBuy325$6.96$2,262.00 7/24/2025Lynx1 Capital Management LpMajor ShareholderBuy66,423$5.71$379,275.33 7/23/2025Lynx1 Capital Management LpMajor ShareholderBuy49,302$5.74$282,993.48 7/22/2025Lynx1 Capital Management LpMajor ShareholderBuy13,123$5.44$71,389.12 6/26/2025Orbimed Advisors LlcMajor ShareholderSell10,662$6.60$70,369.20 6/25/2025Orbimed Advisors LlcMajor ShareholderSell6,940$6.60$45,804.00 6/24/2025Orbimed Advisors LlcMajor ShareholderSell11,580$7.00$81,060.00 4/24/2025Orbimed Advisors LlcMajor ShareholderSell3,409$6.40$21,817.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/22/2025Orbimed Advisors LlcMajor ShareholderSell3,902$6.80$26,533.60 4/17/2025Orbimed Advisors LlcMajor ShareholderSell3,854$6.60$25,436.40 4/15/2025Orbimed Advisors LlcMajor ShareholderSell516$7.60$3,921.60 1/13/2025Orbimed Advisors LlcMajor ShareholderSell899$12.80$11,507.20 1/10/2025Orbimed Advisors LlcMajor ShareholderSell6,310$13.20$83,292.00 1/8/2025Orbimed Advisors LlcMajor ShareholderSell3,750$13.60$51,000.00 1/6/2025Orbimed Advisors LlcMajor ShareholderSell974$15.40$14,999.60 12/27/2024Lynx1 Capital Management LpMajor ShareholderBuy18,682$13.00$242,866.00 12/20/2024Orbimed Advisors LlcMajor ShareholderSell11,516$12.00$138,192.00 12/11/2024Orbimed Advisors LlcMajor ShareholderSell4$16.00$64.00 12/9/2024Orbimed Advisors LlcMajor ShareholderSell2,709$16.80$45,511.20 12/6/2024Orbimed Advisors LlcMajor ShareholderSell1,045$16.40$17,138.00 12/4/2024Orbimed Advisors LlcMajor ShareholderSell3,810$15.80$60,198.00 11/27/2024Lynx1 Capital Management LpMajor ShareholderBuy1,465$13.40$19,631.00 11/25/2024Lynx1 Capital Management LpMajor ShareholderBuy12,999$11.20$145,588.80 9/18/2024Orbimed Advisors LlcMajor ShareholderSell1,281$14.60$18,702.60 9/16/2024Orbimed Advisors LlcMajor ShareholderSell3,155$14.80$46,694.00 (Data available from 1/1/2013 forward) PASG Insider Trading Activity - Frequently Asked Questions Who is on Passage Bio's Insider Roster? The list of insiders at Passage Bio includes Alexandros Fotopoulos, Kathleen Borthwick, Lynx1 Capital Management Lp, Mark S Forman, Orbimed Advisors Llc, Sandip Kapadia, and Simona King. Learn more on insiders at PASG. What percentage of Passage Bio stock is owned by insiders? 5.00% of Passage Bio stock is owned by insiders. Learn more on PASG's insider holdings. Which Passage Bio insiders have been buying company stock? The following insider purchased PASG shares in the last 24 months: Lynx1 Capital Management Lp ($1,365,469.90). How much insider buying is happening at Passage Bio? Insiders have purchased a total of 194,002 PASG shares in the last 24 months for a total of $1,365,469.90 bought. Which Passage Bio insiders have been selling company stock? The following insiders have sold PASG shares in the last 24 months: Kathleen Borthwick ($1,416.20), Mark S Forman ($15,949.40), and Orbimed Advisors Llc ($762,241.00). How much insider selling is happening at Passage Bio? Insiders have sold a total of 77,260 Passage Bio shares in the last 24 months for a total of $779,606.60 sold. Passage Bio Key ExecutivesDr. William Chou M.D. (Age 50)President, CEO & Director Compensation: $945.73kMr. Edgar B. Cale Esq. (Age 60)J.D., General Counsel & Company Secretary Compensation: $804.69kDr. Mark Forman M.D. (Age 60)Ph.D., Chief Medical Officer Compensation: $866.31kDr. James M. Wilson M.D. (Age 69)Ph.D., Co-Founder & Chief Scientific Advisor Ms. Kathleen Borthwick (Age 47)Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer Mr. Stuart M. HendersonSenior Vice President of Corporate Development & Investor RelationsEden FucciSenior Vice President of Technical OperationsDr. Sue Browne Ph.D.Senior Vice President of Research & DevelopmentDr. Karl Whitney Ph.D.Senior Vice President of Global Regulatory Affairs More Insider Trading Tools from MarketBeat Related Companies Atara Biotherapeutics Insider Transactions Sutro Biopharma Insider Transactions Artiva Biotherapeutics Insider Transactions Vaxart Insider Transactions Ovid Therapeutics Insider Transactions Acumen Pharmaceuticals Insider Transactions Quince Therapeutics Insider Transactions OKYO Pharma Insider Transactions Elutia Insider Transactions PMV Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:PASG) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PASG Stock Alerts